Company attributes
Industry
B2X
Founder
Legal Name
Vectalys SAS
Date Incorporated
December 23, 2019
Spinout
Number of Employees (Ranges)
11 – 50
Full Address
Canal Biotech II, 3 rue des satellites, Toulouse, 31400, FR
Founded Date
January 1, 2005
Phone Number
+33561287075
Total Funding Amount (USD)
6,001,071
Latest Funding Round Date
June 2017
Latest Funding Type
Patents Assigned (Count)
2
Country
Other attributes
Company Operating Status
Active
Vectalys is the lentiviral manufacturing platform of Flash Therapeutics. The company specializes in lentiviral technology manufacturing with a record in vector design & production. Vectalys’ platform provides custom and premade lentiviral particles, for research and development purposes.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.